pV132-vCas9
(Plasmid
#203223)
-
PurposeMammalian expression of vCas9
-
Depositing Labs
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 203223 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepX165
- Total vector size (bp) 8214
-
Vector typeMammalian Expression, AAV, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namevCas9
-
SpeciesSynthetic; S. pyogenes
-
Insert Size (bp)4272
-
MutationS55R R976A K1003A T1314R
- Promoter CBh
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BshTI (unknown if destroyed)
- 3′ cloning site EcoRI (unknown if destroyed)
- 5′ sequencing primer CBh-FWD
- 3′ sequencing primer bGH-REV (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pV132-vCas9 was a gift from Vikash Chauhan & Robert Langer & Phil Sharp (Addgene plasmid # 203223 ; http://n2t.net/addgene:203223 ; RRID:Addgene_203223) -
For your References section:
Altered DNA repair pathway engagement by engineered CRISPR-Cas9 nucleases. Chauhan VP, Sharp PA, Langer R. Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2300605120. doi: 10.1073/pnas.2300605120. Epub 2023 Mar 7. 10.1073/pnas.2300605120 PubMed 36881621